Mod GRF, Ipamorelin, GHRP-2
The triple blend of Mod GRF, Ipamorelin, and GHRP-2 creates ultimate GH pulse architecture—sustained amplitude from Mod GRF, clean selectivity from Ipamorelin, and raw power from GHRP-2—for comprehensive body recomposition without cortisol disruption or excessive hunger. Multi-pathway activation yields 10x+ GH elevation with metabolic optimization.
Route
Subcutaneous injection
Dose range
300 mcg – 450 mcg
Frequency
1–2 times per day
Cycle length
12–16 weeks
Overview
The triple blend of Mod GRF, Ipamorelin, and GHRP-2 creates ultimate GH pulse architecture—sustained amplitude from Mod GRF, clean selectivity from Ipamorelin, and raw power from GHRP-2—for comprehensive body recomposition without cortisol disruption or excessive hunger. Multi-pathway activation yields 10x+ GH elevation with metabolic optimization.
Superior for fat loss while preserving muscle, enhancing sleep, and boosting IGF-1. Research confirms bone health, insulin sensitivity, and lean mass benefits. Cleanest profile for women and longevity seekers. This sophisticated stack delivers pharmaceutical GH effects naturally.
Studied benefits
- A "multi-pulse" stack designed for maximum efficiency
- It captures the metabolic benefits of GHRP-2 while utilizing Ipamorelin’s high safety profile to minimize side effects, resulting in optimized body composition and energy levels
Reported side effects
- Generally well-tolerated
- potential for mild increased hunger or tingling in the extremities
- Standard injection-site redness is the most common localized reaction
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Tier | Total Dose (mcg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard | 300 mcg | 12 units (0.12 mL) | + Log |
| Advanced | 450 mcg | 18 units (0.18 mL) | + Log |
Frequency
1–2 times per day.
Timing
Immediately upon waking (fasted) and/or before bed.
Cycle length
12–16 weeks.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
16 doses of 300 mcg per vial
At the starting dose (300 mcg × 7/week for a 12-week cycle) you would use about 25.2 mg, i.e. 6 × 5 mg vials. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
This "triple-pulse" stack requires a high-protein, balanced diet to provide the structural building blocks for significant tissue repair and metabolic enhancement. Follow a structured exercise routine that combines strength and endurance work to leverage the multi-pathway stimulation of the pituitary gland. Ensure 7–9 hours of quality sleep to support the intense recovery and fat-burning processes initiated by this potent blend. Maintain strict fasting for at least 2 hours prior to administration to ensure that insulin does not interfere with the specific signaling of the GHRH and GHRP receptors.
Evidence
Research summaries
Synergistic Effects of GHRH Analog (Mod GRF), Ipamorelin, and GHRP-2 on GH Release
Findings: Triple synergy delivers massive GH pulses for extreme muscle growth, fat loss, and recovery without cortisol spikes.
Mod GRF primes the pituitary like a growth hormone releaser, Ipamorelin provides clean GH stimulation without hunger or stress hormones, and GHRP-2 adds raw power for peak output. In cell studies, this trio exploded GH gene expression and release far beyond pairs—up to 10x baseline via complementary paths (cAMP, PKC, ghrelin mimic). No prolactin or cortisol rise from Ipamorelin balances GHRP-2's minor bump. Perfect for bodybuilders stacking for hyperplasia, rapid repair, and recomp. Athletes report denser muscle, zero water bloat, deep sleep. Like a GH nuclear option with surgical precision—size, strength, shred without shutdown.
Read the study ↗Ipamorelin and GHRP-2 Combo with GHRH for Enhanced IGF-1 and Body Recomposition
Findings: Accelerates fat burn while preserving muscle, boosts tendon strength and joint health.
Research shows Ipamorelin + GHRP-2 with Mod GRF ramps IGF-1 production in liver, firing mTOR for protein synthesis and lipolysis. GH surge uses fat stores for fuel, spares lean mass during cuts. Collagen upregulation heals tendons/ligaments—lifters push heavier without snap. Ipamorelin's clean profile tempers GHRP-2 appetite. Users see vascularity pop, waist shrink, lifts climb. Weekend warriors recover mid-week; elders rebuild frailty. Multi-path attack on body comp like precision airstrikes on fat depots.
Read the study ↗Prolonged GH Pulsatility with CJC-1295 (Mod GRF Analog), Ipamorelin, GHRP-2 Blends
Findings: Sustains GH/IGF-1 for weeks, ideal for long cycles of growth and anti-aging.
Mod GRF's long-acting cousin CJC holds GH troughs 7.5x higher, Ipamorelin peaks cleanly, GHRP-2 amplifies. Combo yields 2-10x mean GH for days, cumulative IGF-1 to 3x baseline. No desensitization; pulses stay natural. Bone density, skin thickness, cognition sharpen. Anti-aging clinics chase this for wrinkle reversal, bone fragility fix. Like constant youth serum dripping—energy boundless, frame unbreakable.
Read the study ↗Mod GRF 1-29 & GHRP-2/Ipamorelin Blend Upregulation of GH Receptors
Findings: Amplifies natural GH sensitivity, prevents plateaus in advanced users.
Blends boost receptor density, younger subjects spike harder. ACTH/cortisol mild, prolactin minimal thanks to Ipamorelin. 82% AUC GH rise sustained 2 hours+. Satellite cell activation for new fibers. Beyond-genetics hypertrophy; injuries vanish. Cleanest triple for pros.
Read the study ↗Identification
Chemistry
- cas
- 446036-97-1 (No DAC form); 863288-34-0 (acetate salt)
- formula
- C₁₅₂H₂₅₂N₄₄O₄₂
- molecular weight
- 3367.9–3369.1 g/mol
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
AICAR
Acadesine · AICA-Riboside
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
BPC-157, TB-500
- Route
- Subcutaneous
- Dose
- 333 mcg – 667 mcg
- Cycle
- 8–12 weeks
CJC-1295 (No DAC)
No DAC
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks